Drug Database
Back to search

United States· US:70461-026_09bab40b-c217-4f1f-b9fd-bfeb0f8f9486

FLUAD

A medicinal product containing influenza a virus a/missouri/11/2025 ivr-279 (h1n1) antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 ivr-285 (h3n2) antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated), registered in United States by Seqirus, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFLUADATC—REGISTER NO.US:70461-026_09bab40b…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about influenza a virus a/missouri/11/2025 ivr-279 (h1n1) antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 ivr-285 (h3n2) antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
Manufacturer
Seqirus, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    70461-026-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b620b61b-a2a5-4f60-aaa7-1e5376fdb689
GET /v1/drugs/b620b61b-a2a5-4f60-aaa7-1e5376fdb689?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR",
  "source": "ndc",
  "strength": "15; 15; 15",
  "substance": "INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)",
  "productndc": "70461-026",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "ug/.5mL; ug/.5mL; ug/.5mL",
  "application_number": "BLA125510",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about influenza a virus a/missouri/11/2025 ivr-279 (h1n1) antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 ivr-285 (h3n2) antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console